IRIS
MARTORANA, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.965
AS - Asia 4.088
EU - Europa 3.237
SA - Sud America 545
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 13
Totale 37.936
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.864
SG - Singapore 2.193
CN - Cina 669
IT - Italia 665
DE - Germania 454
BR - Brasile 452
RU - Federazione Russa 430
UA - Ucraina 394
HK - Hong Kong 363
VN - Vietnam 312
IE - Irlanda 297
FR - Francia 238
GB - Regno Unito 190
KR - Corea 132
FI - Finlandia 127
JP - Giappone 113
NL - Olanda 107
SE - Svezia 104
PL - Polonia 93
IN - India 65
CA - Canada 56
AR - Argentina 40
BD - Bangladesh 35
AT - Austria 31
TR - Turchia 28
ID - Indonesia 27
MX - Messico 25
ZA - Sudafrica 23
ES - Italia 22
UZ - Uzbekistan 20
CZ - Repubblica Ceca 19
BE - Belgio 17
IQ - Iraq 17
EC - Ecuador 16
KG - Kirghizistan 14
SA - Arabia Saudita 14
CL - Cile 13
PH - Filippine 13
AU - Australia 12
EU - Europa 12
PK - Pakistan 12
KE - Kenya 11
MA - Marocco 9
MY - Malesia 9
PY - Paraguay 9
TN - Tunisia 8
DK - Danimarca 6
JO - Giordania 6
VE - Venezuela 6
BG - Bulgaria 5
CH - Svizzera 5
IL - Israele 5
LT - Lituania 5
NP - Nepal 5
AZ - Azerbaigian 4
CO - Colombia 4
CR - Costa Rica 4
EG - Egitto 4
ET - Etiopia 4
GR - Grecia 4
OM - Oman 4
TW - Taiwan 4
CG - Congo 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
MD - Moldavia 3
NO - Norvegia 3
PE - Perù 3
PS - Palestinian Territory 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DM - Dominica 2
DZ - Algeria 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
TH - Thailandia 2
UY - Uruguay 2
ZM - Zambia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BM - Bermuda 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
KH - Cambogia 1
KW - Kuwait 1
Totale 37.921
Salva come PNG Salva come JPEG
Città #
Woodbridge 8.024
Wilmington 7.325
Houston 7.088
Fairfield 1.069
Singapore 985
Ann Arbor 667
Ashburn 620
Chandler 465
San Jose 452
Seattle 427
Hong Kong 357
Cambridge 342
Jacksonville 329
Beijing 279
Dublin 277
Medford 218
Rome 216
Dearborn 211
New York 168
Santa Clara 141
The Dalles 110
Los Angeles 107
Ho Chi Minh City 102
Lawrence 102
Council Bluffs 100
Tokyo 99
Moscow 79
Lauterbourg 73
Hanoi 72
Munich 72
Kraków 62
Buffalo 59
San Diego 59
Mülheim 51
São Paulo 46
Milan 45
Helsinki 44
Menlo Park 43
Zhengzhou 42
Chicago 36
Manchester 35
London 30
Dallas 29
Norwalk 29
Palo Alto 28
Warsaw 28
Redondo Beach 24
Atlanta 23
Maastricht 23
Nuremberg 23
Orem 21
Rio de Janeiro 21
Brooklyn 20
Redwood City 20
Chennai 19
Johannesburg 19
Hangzhou 18
Vienna 18
Amsterdam 17
Brussels 17
Da Nang 17
North Bergen 17
Düsseldorf 16
Montreal 16
Verona 16
Brno 15
Frankfurt am Main 15
Tashkent 15
Toronto 15
Phoenix 14
San Francisco 14
Stockholm 14
Boardman 13
Columbus 13
Poplar 13
Seoul 13
Shanghai 13
Dhaka 12
Falls Church 12
Hefei 12
Jakarta 12
University Park 12
Belo Horizonte 11
Denver 11
Guangzhou 11
Pieve a Nievole 11
Saint Petersburg 11
Turku 11
Biên Hòa 10
Brasília 10
Del Norte 10
Ferrara 10
Haiphong 9
Madrid 9
Mexico City 9
Miami 9
Nairobi 9
Nanjing 9
Baghdad 8
Boston 8
Totale 32.010
Salva come PNG Salva come JPEG
Nome #
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response. 596
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation 517
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease 515
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. 505
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 492
Association between alzheimer's disease and glaucoma: A study based on heidelberg retinal tomography and frequency doubling technology perimetry 491
Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. 487
Transient global amnesia: linked to a systemic disorder of amino acid catabolism? 485
Assessment of Optic Nerve Head and Retinal Nerve Fibre Layer Changes and Evaluation of Frequency of Glaucoma in Patients with Alzheimer's Disease 477
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. 477
Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? 467
"Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals" 466
Impaired LTP- but not LTD-Like Cortical Plasticity in Alzheimer's Disease Patients 464
Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. 462
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 461
Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients 460
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients 459
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology 459
Adult polyglucosan body disease: Proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene 457
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 456
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease 455
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 454
Bromelain degrades Aβ1-42 monomers and soluble aggregates: an in vitro study in cerebrospinal fluid of Alzheimer's disease patients 452
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain 450
Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons 448
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 446
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism? 443
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. 443
Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients 442
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 438
Dopaminergic Modulation of Cortical Plasticity in Alzheimer's Disease Patients 438
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? 437
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD 436
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 435
P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex 433
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 432
Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins 431
Huntingtin distribution among striatal output neurons of normal rat brain 431
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 431
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain. 430
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 428
Reversal of LTP-Like cortical plasticity in Alzheimer's disease patients with tau-related faster clinical progression 421
Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study 419
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 418
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 418
Tissue plasminogen activator is required for corticostriatal long-term potentiation 415
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 415
Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by handling temperature: indication of reversible Abeta1-42 aggregation? 413
Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease. 413
Detection of Aβ42 in the CSF of Alzheimer’s disease is influenced by handling temperature: indication of a reversible process of Aβ42 aggregation in vivo? 411
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 410
Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra 410
D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation 410
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 410
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease. 409
Kyphoplasty: a new opportunity for rehabilitation of neurologic disabilities 407
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 405
Plasmin system of Alzheimer's disease patients: CSF analysis 405
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 399
Functional correlates of t-Tau, p-Tau and Aβ1-42 amyloid cerebrospinal fluid levels in Alzheimer's disease: A 18F-FDG PET/CT study 392
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms 388
L-dopa modulates motor cortex excitability in Alzheimer's disease patients 387
Frailty among Alzheimer's disease patients 386
Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle 384
Zinc distribution in various tissues, (brain, eye, skin, muscle and blood) of rat during hindlimb suspension 373
Is dopamine involved in Alzheimer's disease? 369
Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients 368
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 363
Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients. 358
The Load of Amyloid-β Oligomers is Decreased in the Cerebrospinal Fluid of Alzheimer's Disease Patients 354
Muscle regeneration in mdx mice: Resistance to repeated necrosis is compatible with myofiber maturity 354
Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset 349
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 341
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: A F-18 FDG PET/CT study 313
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 310
Assessment of serum uric acid as risk factor for tauopathies 303
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study 300
Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia 251
Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial 235
Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study 224
The role of epsilon phenotype in brain glucose consumption in Alzheimer’s disease 214
Alzheimer’s disease and the routine clinical use of CSF biomarkers 198
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients. 195
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 183
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial 174
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 168
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment 167
Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer's disease carrying apolipoprotein E4 genotype 158
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 154
Insulin and the future treatment of Alzheimer’s disease 154
Ageing as a Trait de Union between diabetes and dementia for frailty 147
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease 145
Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State 142
Transcranial magnetic stimulation: emerging biomarkers and novel therapeutics in Alzheimer's disease 131
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia 122
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias 112
Hearing and cognitive impairment: a functional evaluation of associative brain areas in patients affected by Alzheimer's disease 105
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype 105
The brain metabolic correlates of the main indices of neuropsychological assessment in Alzheimer’s disease 105
Breakdown of TMS evoked EEG signal propagation within the default mode network in Alzheimer’s disease 104
Totale 36.379
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.652
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021217 0 0 0 0 0 0 0 0 0 0 177 40
2021/20221.167 55 158 86 37 32 114 55 88 71 80 73 318
2022/20231.285 144 111 45 131 100 297 109 58 114 16 109 51
2023/2024498 58 16 31 25 42 148 20 44 10 10 6 88
2024/20253.079 84 631 289 162 77 222 132 117 305 259 405 396
2025/20264.830 394 230 523 439 480 180 727 654 670 512 21 0
Totale 38.364